STOCK TITAN

QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP

(Very Positive)
Tags

QTREX Quantum (Nasdaq: QTEX) launched a research collaboration with Northeastern University in Massachusetts to develop advanced micro-system structures for cryogenic quantum interconnects. Under the agreement, Northeastern granted QTREX a first option to negotiate a commercial license to Northeastern-owned or jointly developed Project IP arising directly from the joint research.

The program is designed to expand QTREX’s vertically integrated quantum connectivity platform by adding a structured innovation pipeline alongside its proprietary materials, advanced manufacturing and cryogenic interconnect capabilities. Joint teams have already begun work to define research objectives, align technical priorities and allocate responsibilities.

Loading...
Loading translation...

Positive

  • Research collaboration with Northeastern University focused on cryogenic quantum interconnect micro-systems
  • First option to negotiate license for Northeastern-owned or jointly developed Project IP
  • Program already commenced with joint teams defining objectives and responsibilities
  • Broadens quantum connectivity platform via structured innovation pipeline and proprietary AME-based technologies

Negative

  • None.

News Explained

The headline’s “commercialization rights” are narrower in the agreement: QTREX receives a first option to negotiate a commercial license to project-generated IP, rather than a stated license itself.

Market Context

The historical record shows a -0.90% reaction to a comparable cryogenic-interconnect development ann...
Analysis

The historical record shows a -0.90% reaction to a comparable cryogenic-interconnect development announcement. The active F-3 is a resale registration, and no recent insider activity was reported; subsequent research milestones and licensing terms remain relevant.

Historical Context

5 past events · Latest: May 19 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
May 19 Ticker transition Positive +2.1% Company renamed QTREX and announced a strategic focus on AME and quantum connectivity.
May 18 Purchase order Positive -5.8% NYU Langone issued a $580,000 order following evaluation of more than 30 cases.
May 11 Strategic update Positive -6.3% Management outlined AME, quantum connectivity, and medical-asset monetization initiatives.
May 01 AME system order Positive +5.8% Company secured a $596,000 AME system order from an Irish research university.
Apr 30 Cryogenic collaboration Positive -0.9% Company and Qarakal began joint development of cryogenic interconnects for quantum systems.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent positive strategic and commercial announcements produced mixed 24-hour reactions, ranging from a 5.76% gain to a 6.27% decline.

Key Terms

additively manufactured electronics, cryogenic interconnects, superconducting materials, dilution cryostats
4 terms
additively manufactured electronics technical
"focused on advancing Additively Manufactured Electronics (AME) for quantum computing infrastructure"
Additively manufactured electronics are electronic components and circuits created by layer-by-layer printing techniques instead of traditional machining or assembly. Think of building a cake where each layer can contain wiring, sensors or conductive traces so a finished part can combine structure and electronics in one piece. For investors, this can cut production time and part counts, enable custom or lightweight designs, and open new product opportunities or cost savings across manufacturing and supply chains.
cryogenic interconnects technical
"focused on advanced micro-system structures for cryogenic quantum interconnects"
Hardware links — such as specialized wires, connectors, cables, and circuit traces — that carry electrical, optical, or microwave signals between components kept at very low (cryogenic) temperatures. They are engineered to preserve signal quality and minimize heat transfer so delicate low-temperature devices can function. Investors care because these components affect the performance, scalability, reliability, and cost of technologies that require cold environments, like superconducting and quantum systems; think of them as well-insulated pipes that move sensitive signals between freezer rooms without warming them.
superconducting materials technical
"including the evaluation of conductive, dielectric and superconducting materials"
Materials that can carry electric current with effectively zero electrical resistance and expel magnetic fields when cooled below a specific critical temperature. Like a frictionless highway for electrons, they can enable much more efficient power transmission, stronger magnets for medical imaging and transportation, and components for quantum computing — qualities that can change cost structures, product capabilities, and market opportunities for companies involved in their development or use.
dilution cryostats technical
"quantum connectivity solutions for dilution cryostats"
A dilution cryostat is a laboratory machine that creates extremely low temperatures—thousandths of a degree above absolute zero—by using a special mixture of helium isotopes. Think of it as a super-powerful freezer that lets researchers test and run delicate technologies such as quantum processors and ultra-sensitive sensors. For investors, access to or development of these systems signals involvement in advanced, capital-intensive technologies with long development cycles and potential for high strategic value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Ness Ziona, Israel, July 27, 2026 (GLOBE NEWSWIRE) -- QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP

Ness Ziona, Israel, July 27, 2026 – QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure today announced the launch of a research collaboration with Northeastern University in Massachusetts, focused on advanced micro-system structures for cryogenic quantum interconnects. Pursuant to the collaboration agreement, Northeastern University has agreed to provide QTREX with a first option to negotiate a commercial license to Northeastern-owned or jointly developed intellectual property arising directly from the parties’ joint research (the “Project IP”). The program further expands QTREX’s vertically integrated quantum connectivity platform by adding a structured innovation pipeline alongside the Company’s proprietary materials, advanced manufacturing and cryogenic interconnect capabilities.

The research activities are expected to focus on micro-system structures and interconnect geometries that may support new quantum connectivity architectures, including the evaluation of conductive, dielectric and superconducting materials for cryogenic environments and characterization of fabricated structures under cryogenic conditions. These activities are intended to generate experimental data and technical insights that can strengthen QTREX’s long-term innovation pipeline and inform future quantum connectivity, packaging and processor-interface solutions.

Northeastern University, a leading R1 research university, the highest US research activity designation, with a dedicated quantum research ecosystem anchored by its Quantum Materials and Sensing Institute, brings capabilities in quantum materials, superconducting devices, nanofabrication, advanced characterization and quantum sensing. The research effort will be led by Prof. Benyamin Davaji, whose work in advanced micro-systems, microfabrication and NSF-funded superconducting nanowire detector research provides quantum-relevant expertise directly aligned with QTREX’s structured innovation pipeline.

"Additive manufacturing of electronics and microsystems holds exciting potential to reshape how we approach electrical connectivity—offering a path toward three-dimensional, low-parasitic interconnects with micron-scale precision that could benefit both quantum sensing and quantum computing," said Prof. Benyamin Davaji, Professor of Electrical and Computer Engineering at Northeastern University.

“We believe that the combination of our proprietary technology platform with the deep scientific knowledge, research infrastructure and years of experience of Northeastern University’s researchers, led by Prof. Benyamin Davaji, creates a powerful foundation for breakthrough developments in quantum interconnect architectures,” said Dagi Ben-Noon, CEO of QTREX. “Our strategy is to build a comprehensive quantum connectivity platform by combining proprietary materials, advanced manufacturing, processor-interface technologies and a continuously expanding innovation pipeline. This program strengthens that strategy by creating a structured pathway to translate academic research and eligible project-generated IP into potential commercial technologies for next-generation quantum systems.”

The program has already commenced, with joint teams from QTREX and Northeastern University beginning to work together to define research objectives, align technical priorities and allocate responsibilities.

About QTREX Quantum

QTREX Quantum Ltd. (Nasdaq: QTEX) is a technology company focused on advanced connectivity and electronics manufacturing solutions for next-generation hardware markets. Following its acquisition of the AME platform, the Company is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile, space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory support and blood monitoring platforms, while actively working to monetize certain parts of the medical business.

For more information, please visit: www.q-trex.com

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the expected scope and goals of the collaboration with Northeastern University and the belief that the combination of the Company’s proprietary technology platform with the deep scientific knowledge, research infrastructure and years of experience of Northeastern University’s researchers creates a powerful foundation for breakthrough developments in quantum interconnect architectures. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained under “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission.

Company Contact
QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664485

Attachment


FAQ

What did QTREX Quantum (Nasdaq: QTEX) announce on July 27, 2026 about its quantum interconnect program?

QTREX Quantum announced a new research collaboration with Northeastern University focused on cryogenic quantum interconnect micro-systems. According to QTREX, the program expands its vertically integrated quantum connectivity platform and adds a structured innovation pipeline to support future quantum connectivity and processor-interface solutions.

What commercialization rights does QTREX (QTEX) receive from the Northeastern University quantum interconnect project?

QTREX receives a first option to negotiate a commercial license for Northeastern-owned or jointly developed Project IP created by the collaboration. According to QTREX, this structure aims to translate eligible research outcomes into potential commercial technologies for next-generation quantum connectivity and packaging solutions.

How does the Northeastern University collaboration support QTREX Quantum’s AME-based quantum connectivity strategy?

The collaboration supports QTREX’s strategy by targeting micro-system structures and interconnect geometries for cryogenic quantum environments. According to QTREX, these activities complement its proprietary AME materials, advanced manufacturing and cryogenic interconnect capabilities as part of a comprehensive quantum connectivity platform.

Who is leading the Northeastern research effort in the QTREX (QTEX) quantum interconnect program?

The research effort is led by Prof. Benyamin Davaji, Professor of Electrical and Computer Engineering at Northeastern University. According to QTREX, his background in advanced micro-systems, microfabrication and NSF-funded superconducting nanowire detector research aligns closely with the project’s quantum interconnect objectives.

Has QTREX Quantum’s collaboration with Northeastern University on quantum interconnects already started?

Yes, QTREX reports that the program has already commenced with joint teams from QTREX and Northeastern University. According to QTREX, the teams are working to define research objectives, align technical priorities and allocate responsibilities for the quantum interconnect research activities.

What technologies and markets is QTREX Quantum (QTEX) targeting beyond the new quantum interconnect program?

QTREX is developing high-density, thermally optimized quantum connectivity solutions for dilution cryostats and AME applications for defense, aerospace, missile and space markets. According to QTREX, it also advances medical technologies in respiratory support and blood monitoring while seeking to monetize parts of its medical business.